5395242026-08-03Disclosure45395242026-08-03Disclosure35395242026-08-03Disclosure25395242026-08-03Disclosure15395242026-08-035395242026-08-03Disclosure65395242026-08-03Disclosure5xbrli:sharesxbrli:pureiso4217:INR

Prohibition of Insider Trading


DR. LAL PATHLABS LIMITED

General information about company

Scrip Code539524
NSE SymbolLALPATHLAB
MSEI SymbolNOTLISTED
Name of the SignatoryVINAY GUJRAL
Designation of SignatoryCompany Secretary and Compliance Officer
PlaceGURUGRAM
Date of Filing03-08-2026
ISIN CodeINE600L01024
Disclosure under RegulationRegulation 7 (2)
Revised FilingNo

PIT Disclosure

Sr. No.Type of instrumentDescription of type of instrument (applicable in case of other is selected)Category of personName of the personCIN / DINSecurities held prior to acquisition / disposalSecurities acquired / disposedSecurities held post acquisition / disposalDate of allotment advice / acquisition of shares / sale of shares specifyMode of acquisition / disposalDate of intimation to companyType of contractContract specificationBuySellExchange on which the trade was executedNotes
No. of security% of shareholdingNo. of securityValue of security (in Rs.)Transaction typeNo. of security% of shareholdingFrom dateTo dateNotional valueNo. of units (contracts × lot size)Notional valueNo. of units (contracts × lot size)
1EquityDesignated PersonAmit Aggarwal00.00%5002,500.00Buy5000.00%30-07-202630-07-2026ESOP03-08-2026NATextual Information(1)
2EquityDesignated PersonAmit Aggarwal5000.00%250474,750.00Sell2500.00%31-07-202631-07-2026Market Sale03-08-2026NSE
3EquityDesignated PersonAmit Aggarwal2500.00%250478,549.00Sell00.00%03-08-202603-08-2026Market Sale03-08-2026BSE
4EquityDesignated PersonJai Prakash Meena54000.00%34006,375,000.00Sell20000.00%31-07-202631-07-2026Market Sale03-08-2026NSE
5EquityDesignated PersonManoj Kumar Garg549000.03%500950,000.00Sell544000.03%30-07-202630-07-2026Market Sale03-08-2026NSE
6EquityDesignated PersonManoj Kumar Garg544000.03%500954,900.00Sell539000.03%31-07-202631-07-2026Market Sale03-08-2026BSE

Text Block

Textual Information(1)It may be kindly noted that shares were acquired at Effective Exercise price (Post Bonus Issue- 2025) of 5/- per share (as the case maybe) under Company’s ESOP plan.